The DOI matches its Crossref record, with a small difference in title or year; 11 of the 11 references it cites were found in a registry or an index.
Controlled Release of LHRH Agonist, Leuprolide Acetate, from Microcapsules: Serum Drug Level Profiles and Pharmacological Effects in Animals
Abstract
The pharmacokinetic behaviour of leuprolide acetate from a controlled release parenteral dosage form has been studied in rats and dogs. The release of the drug in rats after a single subcutaneous injection exhibited pseudo-zero-order kinetics for one month in doses ranging from 0.0135 to 1.35 mg/rat; the release rate at a dose of 1.35 mg/rat was 2.8% of dose/day; after intramuscular injection the response was similar. In rats, the serum leuprolide acetate levels increased sharply immediately after injection by either route as a consequence of the initial release of the drug; subsequently, the levels attained a plateau for two weeks. The serum level profiles in dogs showed essentially the same pattern as those in rats. When the dosage form was injected into rats, the serum testosterone level (a pharmacological index) sharply peaked, abruptly decreased to below the normal level, and then was sustained at a suppressed level for over six weeks at a dose of 1.35 mg/rat (equivalent to 3 mg kg-1) and higher, while the serum testosterone level after an injection of 0.0135 and 0.135 mg/rat was not sufficiently suppressed. The profiles in dogs showed essentially the same pattern as those in rats. With multiple administrations (once every 4 weeks), serum testosterone levels in dogs did not show any sharp rise after the second and third injections. Changes in rat reproductive organ weights agreed well with the serum testosterone profile in the suppression. The results demonstrate that th…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with previous findings (26), we found that leuprolide treatment reduced testosterone levels.”
From Puberty Blocker, Leuprolide, Reduces Sex Differences in Rough-and-Tumble Play and Anxiety-like Behavior in Juvenile Rats (2024) · cites this paper as [26]
Citations
Cites
Ogawa, Y., Yamamoto, M., Okada, H., Yashiki, T., & Shimamoto, T. (1988) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.36.1095 · Cited by 506
Self-citationBrady, J. M., Cutright, D. E., Miller, R. A., Battistone, G. C., & Hunsuck, E. E. (1973) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820070204 · Cited by 280
Sanders, L. M., Kent, J. S., McRae, G. I., VICKERY, B. H., Tice, T. R., & Lewis, D. H. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600730927 · Cited by 253
Ogawa, Y., Yamamoto, M., Takada, S., Okada, H., & Shimamoto, T. (1988) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.36.1502 · Cited by 173
Self-citationOgawa, Y., Okada, H., YAMAMOTO, Y., & Shimamoto, T. (1988) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.36.2576 · Cited by 171
Self-citationOkada, H., Heya, T., Ogawa, Y., & Shimamoto, T. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24466-4 · Cited by 116
Self-citationControlled delivery of an LHRH analogue from biodegradable injectable microspheres
Sanders, L. M., McRae, G. I., Vitale, K. M., & Kell, B. A. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90044-6 · Cited by 113
Johnson, E. S., Gendrich, R. L., & White, W. F. (1976) · Fertility and Sterility · doi:10.1016/s0015-0282(16)41963-1 · Cited by 104
Yamazaki, I., & Okada, H. (1980) · Endocrinologia Japonica · doi:10.1507/endocrj1954.27.593 · Cited by 48
Self-citationBiopolymeric controlled release systems
Wise, D. L. (1984) · CRC Press eBooks · Cited by 46
Leuprolide: A Gonadotropin-Releasing Hormone Analog for the Palliative Treatment of Prostatic Cancer
Wojciechowski, N. J., Carter, C. A., Skoutakis, V. A., Bess, D. T., Falbe, W. J., & Mickle, T. R. (1986) · Annals of Pharmacotherapy · doi:10.1177/106002808602001001 · Cited by 19
Research works printed but not linked: 1
- Wise, 1984, Biopolymer system design for sustained release of biological active agents, 3
Cited by
Sorted by citations
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
Wischke, C., & Schwendeman, S. P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.042 · Cited by 821
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 621
Jalil, R., & Nixon, J. R. (1990) · Journal of Microencapsulation · doi:10.3109/02652049009021842 · Cited by 407
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
Okada, H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00050-1 · Cited by 380
Self-citationPolymer conjugates with anticancer activity
Putnam, D. A., & Kopec̆ek, J. (1995) · Advances in polymer science · doi:10.1007/3540587888_14 · Cited by 316
Metadata
- Authors
- Ogawa, Y., Okada, H., Heya, T., & Shimamoto, T.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Ogawa, Yasuaki
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-07-01
- Volume
- 41
- Issue
- 7
- Pages
- 439-444
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2019022309
- Cited by
- 139
- References
- 11
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2016: 3 · 2015: 4 · 2014: 2 · 2013: 5 · 2012: 2
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Pharmacy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- leuprolide, GnRH agonist, controlled release, microcapsules, parenteral dosage forms, pharmacokinetics, serum drug concentration, testosterone suppression, gonadotropin-releasing hormone, reproductive organ weight
- MeSH terms
- Animals, Antineoplastic Agents, Body Weight, Capsules, Chemistry, Pharmaceutical, Delayed-Action Preparations, Dogs, Drug Compounding, Genitalia, Male, Injections, Intramuscular, Injections, Subcutaneous, Gonadotropin-Releasing Hormone, Male, Organ Size, Rats, Inbred Strains, Species Specificity, Testosterone, Time Factors, Leuprolide, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review